JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 26, 2003; DOI: 10.1124/jpet.102.047415


0022-3565/03/3061-13-28$20.00
JPET 306:13-28, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction
Right arrow An erratum has been published
Right arrow All Versions of this Article:
jpet.102.047415v1
jpet.102.047415v2
306/1/13    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Banan, A.
Right arrow Articles by Keshavarzian, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Banan, A.
Right arrow Articles by Keshavarzian, A.
Right arrowPubmed/NCBI databases
*Substance via MeSH

CELLULAR AND MOLECULAR

Evidence That Nuclear Factor-{kappa}B Activation Is Critical in Oxidant-Induced Disruption of the Microtubule Cytoskeleton and Barrier Integrity and That Its Inactivation Is Essential in Epidermal Growth Factor-Mediated Protection of the Monolayers of Intestinal Epithelia

A. Banan, A. Farhadi, J. Z. Fields, E. Mutlu, L. Zhang, and A. Keshavarzian

Departments of Internal Medicine (Section of Gastroenterology and Nutrition), Pharmacology, and Molecular Physiology, Rush University Medical Center, Chicago, Illinois

Using monolayers of intestinal (Caco-2) cells, we showed that oxidants disrupt the microtubule cytoskeleton and barrier integrity; epidermal growth factor (EGF) was protective via stabilization of the microtubules. Because proinflammatory conditions activate nuclear factor-{kappa}B (NF-{kappa}B), we hypothesized that oxidants disrupt barrier integrity through activation of NF-{kappa}B and that EGF protects by suppressing NF-{kappa}B. Parental cells were pretreated with EGF or NF-{kappa}B or inhibitory {kappa}B{alpha} (I-{kappa}B{alpha}) modulators. Other cells were stably transfected with varying levels of a dominant negative mutant for the NF-{kappa}B inhibitor I-{kappa}B{alpha}. Both types of cells were grown as monolayers and then exposed to oxidant (H2O2). We then monitored monolayer barrier integrity (permeability), stability of the microtubule cytoskeleton (confocal microscopy, immunoblotting), intracellular levels of the I-{kappa}B{alpha} (immunoblotting), translocation, and activity of NF-{kappa}B (immunoblotting, sensitive enzyme-linked immunosorbent assay). Monolayers were also fractionated and processed to assess alterations in 1) polymerized tubulin (S2; an index of cytoskeletal integrity) and 2) monomeric tubulin (S1; an index of disassembly) (polyacrylamide gel electrophoresis fractionation and immunoblotting). We found the following: 1) Oxidants caused I-{kappa}B{alpha} degradation, NF-{kappa}B translocation, NF-{kappa}B (p50 and p65 subunits) activation, tubulin disassembly ({uparrow} S1, {downarrow}S2), microtubule architectural instability, and barrier disruption. I-{kappa}B{alpha} stabilizers and NF-{kappa}B inhibitors [e.g., carbobenzyloxy-leuleu-leucinol (MG-132), lactacystin] suppressed oxidants injurious effects. 2) EGF (10 ng/ml) stabilized I-{kappa}B{alpha} and prevented both NF-{kappa}B translocation and activation while protecting monolayers against oxidants. 3) In stably transfected cells, transfection-induced stabilization of I-{kappa}B{alpha} by itself led to EGF-like protective effects. In these mutant cells, protection was not potentiated by EGF (10 ng/ml). Conclusions are 1) oxidants induce disruption of the cytoskeleton and intestinal barrier integrity, in part, through I-{kappa}B{alpha} degradation and subsequent NF-{kappa}B activation, 2) I-{kappa}B{alpha} stabilization is by itself protective, mimicking EGF, and 3) EGF protects cell monolayers through I-{kappa}B{alpha} stabilization and NF-{kappa}B inactivation. To our knowledge, this is the first report that NF-{kappa}B can affect the dynamics of cytoskeletal assembly and intestinal barrier integrity.


Received for publication January 29, 2003
Accepted March 18, 2003.

Address correspondence to: Dr. A. Banan, Rush University Medical Center, Department of Internal Medicine, Section of Gastroenterology and Nutrition, 1725 W. Harrison, Suite 206, Chicago, IL 60612. E-mail: ali_banan{at}rush.edu




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
P. K. Wong, F. Yu, A. Shahangian, G. Cheng, R. Sun, and C.-M. Ho
Closed-loop control of cellular functions using combinatory drugs guided by a stochastic search algorithm
PNAS, April 1, 2008; 105(13): 5105 - 5110.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. L. Theiss, R. D. Idell, S. Srinivasan, J.-M. Klapproth, D. P. Jones, D. Merlin, and S. V. Sitaraman
Prohibitin protects against oxidative stress in intestinal epithelial cells
FASEB J, January 1, 2007; 21(1): 197 - 206.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. Qi, A. M. Fox, L. G. Alexopoulos, L. Chi, D. Bynum, F. Guilak, and A. J. Banes
IL-1beta decreases the elastic modulus of human tenocytes
J Appl Physiol, July 1, 2006; 101(1): 189 - 195.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Banan, L. J. Zhang, M. Shaikh, J. Z. Fields, A. Farhadi, and A. Keshavarzian
Novel effect of NF-{kappa}B activation: carbonylation and nitration injury to cytoskeleton and disruption of monolayer barrier in intestinal epithelium
Am J Physiol Cell Physiol, October 1, 2004; 287(4): C1139 - C1151.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Banan, L. J. Zhang, M. Shaikh, J. Z. Fields, A. Farhadi, and A. Keshavarzian
Inhibition of Oxidant-Induced Nuclear Factor-{kappa}B Activation and Inhibitory-{kappa}B{alpha} Degradation and Instability of F-Actin Cytoskeletal Dynamics and Barrier Function by Epidermal Growth Factor: Key Role of Phospholipase-{gamma} Isoform
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 356 - 368.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Banan, L. J. Zhang, A. Farhadi, J. Z. Fields, M. Shaikh, and A. Keshavarzian
PKC-{beta}1 isoform activation is required for EGF-induced NF-{kappa}B inactivation and I{kappa}B{alpha} stabilization and protection of F-actin assembly and barrier function in enterocyte monolayers
Am J Physiol Cell Physiol, March 1, 2004; 286(3): C723 - C738.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Banan, J. Z. Fields, L. J. Zhang, M. Shaikh, A. Farhadi, and A. Keshavarzian
{zeta} Isoform of Protein Kinase C Prevents Oxidant-Induced Nuclear Factor-{kappa}B Activation and I-{kappa}B{alpha} Degradation: A Fundamental Mechanism for Epidermal Growth Factor Protection of the Microtubule Cytoskeleton and Intestinal Barrier Integrity
J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 53 - 66.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.